InnoCare Pharma
(1) 2024
(2) 2024
(3) 2024
(4)
(5)(6)(7)(8)
(9)202562088AGM-1AGM-8
( www.hkexnews.hk )( www.innocarepharma.com )
482025618
17M
2025428
– i –
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
4.2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
5.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
9.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
10.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
12.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
14.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
— 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I-1
– ii –
— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . II-1
— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . III-1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AGM-1
202420241231202420241231
2025620
AGM-1AGM-8
20151139969688428
7%
93%7%
0.000002
III-2
2025424
2020323
202013
a.b.
c.
0.000002
0.000002
1.01
%
??
– 5 –
InnoCare Pharma
Ogier Global (Cayman) Limited89 Nexus Way, Camana BayGrand Cayman, KY1-9009Cayman Islands
(1) 2024
(2) 2024
(3) 2024
(4)
(5)(6)(7)(8)
(9)
1.
AGM-1AGM-8
(1) 2024(2)2024(3)2024(4)
(5)(6)2025
(7)(8)
2. 2024
202420242025328(http://www.sse.com.cn)(http://www.hkexnews.hk)(www.innocarepharma.com)
20242025428(http://www.hkexnews.hk)(http://www.sse.com.cn)(www.innocarepharma.com)
3. 2024
2024
4. 2024
2024
202420253272024
5.
20%
1,762,567,2021,686,000
352,176,2407
520%
10%
1,494,598,235
266,282,9677149,459,82326,628,296
6.
114.(a)
20251212024925
7.
(a)
(b) 3.13
(c)
3.13
8.
9.
10.
( http://www.hkexnews.hk )2021632022518202266
( http://www.hkexnews.hk )202131120215262021913202241320225112022612022852022822202291202298
( http://www.hkexnews.hk )( http://www.sse.com.cn )
202291620229202025327
2022715[2022]1524
A264,648,217
11.03
2,919.07140.25
2,778.82
2022916[2022]61576403_B01
202532720241231202412311,428.24
1,350.5820241231
20241231
1,494,220.61,494,220.61,085,626.7
116,146.6116,146.621,890.1273,851.4273,851.4113,023.460,952.360,952.328,859.5833,644.7833,644.7101,178.6
2,778,815.62,778,815.61,350,578.3
1.
ICP-19221,285.727,485.72ICP-0336,078.66
2,078.66ICP-B034,862.930
20,841.114,841.11ICP-B794
10,000.0028,662.93
1ICP-022412,306.6—412,306.62ICP-192212,857.2-138,000.074,857.23ICP-723125,046.7—125,046.74ICP-33269,470.4—69,470.45ICP-03360,786.6-40,000.020,786.66ICP-18957,313.1—57,313.17ICP-488154,918.9—154,918.98ICP-49057,868.8—57,868.89ICP-24857,313.1—57,313.110ICP-B0348,629.3-48,629.30.011ICP-B794—100,000.0100,000.0
—286,629.3286,629.313208,411.1-160,000.048,411.11429,298.8—29,298.8
1,494,220.6—1,494,220.6
2.
2,142.471,342.471,675.842,475.84
116,758.48000.024,758.4272,808.6—72,808.6321,424.7-8000.013,424.742,877.5—2,877.552,277.4—2,277.4
116,146.6—116,146.6
3.
3,882.641,082.645,254.38
8,054.38
138,826.4-28,000.010,826.4252,543.828,000.080,543.83177,111.6—177,111.645,369.6—5,369.6
273,851.4—273,851.4
4.
1,245.4402,432.16
3,077.6
274.55874.55
112,454.4-12,454.40.0242,814.6—42,814.6
2.118,493.0—18,493.0
2.224,321.66,454.430,776.032,745.56,000.08,745.542,501.0—2,501.05436.8—
436.8
60,952.3—60,952.3
1.
ICP-B794
(ADC)B7-H3ADCICP-B794
B7-H3ICP-B7942025ICP-B794INDICP-B794
ICP-192ICP-033ICP-B03
ICP-192ICP-033ICP-B03
2.
3.
2.0
(CLL)(SLL)(r/r CLL/SLL)(MCL)(r/r MCL)(MZL)(r/r MZL)
MZLBTK2024
?
1049.14%10
tafasitamab
4.
—
2025327A
—
—
11.
20256172025620
2025616183171712–1716
12.
AGM-1AGM-8
(i)(ii)(iii)
13.
( www.hkexnews.hk )( www.innocarepharma.com )
482025618
14.
15.
16.
(1)2024(2)2024
(3)2024(4)(5)
(6)2025(7)(8)
2025428
2024
– I-1 –
2024
2024
—
2024
2024
2024?
TafasitamabBLA13I/II/III
2.0
2024
– I-2 –
2024
202412
12024.03.281722024.03.28132024.04.22242024.05.13152024.05.30262024.06.25372024.07.17182024.08.20392024.09.253102024.11.112112024.11.265122024.12.171
2024
– I-3 –
1 A
277,881.5620242023
2024
—
— A
2024
– I-4 –
—
AA
e
2024
– I-5 –
20242
2024
20245
20246
20242
2024
– I-6 –
20252025
—
2025327
– II-1 –
13.51(2)
Ph.D.61201511320168182019927
20199610201010MerckCo
2011820158PPD
?
BioDuro LLC(Sino-American Pharmaceutical Association)1750NatureBloodProceedings of the National Academy of SciencesJournal of BiologicalChemistryTransgenic mice expressingAPC resistance Factor Vcloning and expression of dog gonadotropin releasing hormone receptorDNA encoding monkey gonadotropin releasing hormone receptor
19837199212(Purdue University)19969
(The Howard Hughes Medical Institute)
202013
XV103,118,916
– II-2 –
Ph.D.5620151132019927
20028200812
20103Shenzhou Tianchen TechnologyInc.20116201332013720158
20158201841991719995
(Johns Hopkins University)
202013
XV117,439,593
3920213311020082011
2011120157Oriza Cowin2015
2016202020191128
6885782020819
– II-3 –
09926202091802171
2021331
XV
532020311
1875200872018620027
1994720026Arthur Andersen1994720052
(University of Buffalo, the State University of New York)19973CICPA
2020311
30,000XV
– II-4 –
61202381992520079(University of Michigan)20071020236(University of California San Diego)2013
MEK1/2MEKmTORHippomTORC1TSC1/2-RhebRagAMPKmTORC1ULK1VPS34mTORC1mTOR
HippoHippoHippo
15H179
19826198912
19891219919
2025121
30,000
XV
– II-5 –
3.13
(i)(ii)(iii)
13.51(2)(h)(v)
– III-1 –
10%10%
(i)(ii)12(iii)(iv)
(v)
1,496,284,235266,282,9671,686,000
10%
149,459,823
– III-2 –
26,628,29610%
20241231
– III-3 –
(i)
(ii)
(iii)
– III-4 –
HHLR Advisors, Ltd.208,671,22211.83%HHLRAdvisors, Ltd.13.15%
– III-5 –
202511,126,0005.825.576,421,700202412560,0006.125.863,340,550
1,686,0009,762,250
– III-6 –
2024
45.064.03
55.384.22
64.924.31
75.154.31
85.124.38
96.964.87
107.786.20
117.926.04
127.035.802025
16.125.02
210.025.34
310.208.15
410.966.89
– AGM-1 –
InnoCare Pharma
2025620
1. 20241231
2. 2024
3. 2024
4. 20245.
(i) (iii)
(v)
– AGM-2 –
2024611
(ii) (i)
(iii) (i)
(1) (v)(2)
(3)
(4)
20%
– AGM-3 –
(i)
(v)(ii)
(iv)
(v)
(a) (1)
(2)
(i)(ii)
(iii)
(b)
(1)(2)
(3)
– AGM-4 –
(c)
6.
(i) (ii)(iv)
– AGM-5 –
(ii) (i)
10%
(iii) (i)
10%
(iv) (i)(ii)(iii)(i)(ii)(iii)
(v)
(a)(b)
(c)
(d) 12(e)
– AGM-6 –
7.
2024611
10%10%8.9.10.11.12.13.14.
15.
– AGM-7 –
16.
2025428
(i) 567(ii)(iii)
(iv)
4820256
18317M
(v) 202561720256
2025616
171712–1716(vi) 813
2025428(vii) 5
– AGM-8 –
(viii) 6
2025428
(ix)(x) 2025428